fashion -WSS

fashion

author：focus 2025-09-30 00:46:03 - browse：116

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

explore

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Meta looks to target Twitter with a rival app called Threads

Readout LOUD podcast: Live from the 2023 STAT Summit

Grail is spending more than ever lobbying Congress

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Pfizer's Covid pill remains 89% effective in final analysis, company says

explore

fashion

explore

23andMe had bad news about my health. I wish a person had delivered it

The problems with dementia villages

Continuity nursing helped my family in our darkest PICU moments

These geoengineering technologies could help combat the climate crisis, scientists say

In Memoriam: Notable people who died in 2023

A new study asks: Are we harming blood donors by taking blood?

Medicare proposal to cover medical devices draws a mixed reaction

Roche acquires Telavant from Roivant, adding experimental IBD treatment

BioMarin wins approval for gene therapy to treat hemophilia A

Can food be medicine? And other questions about a new push

focus

How AI can help patients find reliable information about doctors

7 people shot in DC, police say

Why a market frenzy over new weight loss drugs defies logic

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Study on Amgen’s bispecific immunotherapy produces positive data

Option Care buys Amedisys in $3.6 billion home care deal

entertainment

explore

knowledge

Wikipedia